Unique ID issued by UMIN | UMIN000042936 |
---|---|
Receipt number | R000048964 |
Scientific Title | EORTC-QLQ-HN43 feasibility study |
Date of disclosure of the study information | 2021/01/08 |
Last modified on | 2024/01/20 14:46:28 |
EORTC-QLQ-HN43 feasibility study
EORTC-QLQ-HN43 feasibility study
EORTC-QLQ-HN43 feasibility study
EORTC-QLQ-HN43 feasibility study
Japan |
head and neck cancer
Hematology and clinical oncology |
Malignancy
NO
To explore the feasibility in assessing quality of life in the patients with head and neck cancer via internet.
Others
field survey
Exploratory
Pragmatic
Not applicable
Response rate for the questionnaires in T1.
Response rate for the questionnaires in T2, the number of rasopnded questions, the number of missing data, reason for the missing data.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) diagnosis of head and neck cancer
2) age 20 year or more
3) receiving chemotherapy at outpatient
4) able to connect internet
5) written informed consent
6) prognosis 3 months or more
1) patient whom physician regard as inappropriate for joining this study
2) unable to QOL questionnaire
40
1st name | Hiroto |
Middle name | |
Last name | Ishiki |
National Cancer Center Hospital
Department of Palliative Medicine
104-0045
5-1-1, Tsukiji, Chuo-ku, Tokyo
0335422511
ishiki-tky@umin.ac.jp
1st name | Hiroto |
Middle name | |
Last name | Ishiki |
National Cancer Center Hospital
Department of Palliative Medicine
104-0045
5-1-1, Tsukiji, Chuo-ku, Tokyo
0335422511
ishiki-tky@umin.ac.jp
Kobe University
Japan Agency for Medical Research and Development
Japanese Governmental office
Institutional Review Board of National Cancer Center
5-1-1, Tsukiji, Chuo-ku, Tokyo
0335422511
none
NO
2021 | Year | 01 | Month | 08 | Day |
none
Published
https://www.annalsofoncology.org/article/S0923-7534(23)01063-3/fulltext
41
Results:40 patients were enrolled between July 2021 and October 2021 at two hospitals in Japan. The completion rate at t1 was 97.5% (95%CI: 86.8-99.9). The completion rate at t2 was 87.5% (95%CI: 73.2-95.8). Missing values were more often observed in the Sexuality (items 60 and 61) and Social eating (items 37 and 53) scales of the HN43.
Conclusions:Online QOL assessment via CHES during the outpatient chemotherapy was feasible in Japanese patients with HNC.
2024 | Year | 01 | Month | 20 | Day |
Patient characteristics were as follows: male 35 cases (87.5%), median age 64 years, 39 (97.5%) underwent palliative chemotherapy, and 25 (62.5%) received immune-checkpoint inhibitors. Twenty (50%) had university or higher education level, 36 (90%) had smartphone, and 20 (50%) had frequent (1<week) access to personal computer.
This was a multicenter, prospective, observational study. Major eligibility criteria were 1) diagnosed with HNC, 2) age > 20 years, 3) underwent chemotherapy at outpatient, and 4) have access to the internet. Eligible patients were asked to answer the EORTC-QLQ-C30 (C30) as well as HN43 via CHES at outpatient visit (t1) and one week later at home by themselves (t2).
none
The primary outcome was the completion rate of the C30 and HN43 at t1. A satisfactory completion of the questionnaire was defined to be achieved when >= 90% of the items were completed. Secondary outcome was the completion rate of the C30 and HN43 at t2.
Main results already published
2020 | Year | 11 | Month | 07 | Day |
2020 | Year | 12 | Month | 08 | Day |
2021 | Year | 02 | Month | 01 | Day |
2022 | Year | 01 | Month | 31 | Day |
NA
2021 | Year | 01 | Month | 07 | Day |
2024 | Year | 01 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048964
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |